CircSMAD3 represses VSMC phenotype switching and neointima formation via promoting hnRNPA1 ubiquitination degradation
Cell Proliferation · 2025
DOI: 10.1111/cpr.13742 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2025. Verfasst von Shuai Mei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuha…. Hauptthemen laut MEDLINE: Ubiquitination, Muscle, Smooth, Vascular, RNA, Circular, Cell Proliferation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Hubei Key Research and Development Program.
Abstract (Originalsprache)
Circular RNAs (circRNAs) are novel regulatory RNAs with high evolutionary conservation and stability, which makes them effective therapeutic agents for various vascular diseases. The SMAD family is a downstream mediator of the canonical transforming growth factor beta (TGF‐β) signalling pathway and has been considered as a critical regulator in vascular injury. However, the role of circRNAs derived from the SMAD family members in vascular physiology remains unclear. In this study, we initially identified potential functional circRNAs originating from the SMAD family using integrated transcriptome screening. circSMAD3, derived from the SMAD3 gene, was identified to be significantly downregulated in vascular injury and atherosclerosis. Transcriptome analysis was conducted to comprehensively illustrate the pathways modulated by circRNAs. Functionally, circSMAD3 repressed vascular smooth muscle cell (VSMC) proliferation and phenotype switching in vitro evidenced by morphological assays, and ameliorated arterial injury‐induced neointima formation in vivo. Mechanistically, circSMAD3 interacted with heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) within the nucleus, enhanced its interaction with E3 ligase WD repeat domain 76 to promote hnRNPA1 ubiquitination degradation, facilitated p53 pre‐RNA splicing, activated the p53γ signalling pathway, and finally suppressed VSMC proliferation and phenotype switching. Our study identifies circSMAD3 as a novel epigenetic regulator that suppresses VSMC proliferation and phenotype switching, thereby attenuating vascular remodelling and providing a new circRNA‐based therapeutic strategy for cardiovascular diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Wuhan, China.
ORCID-Profile: Hu Ding
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Hubei Key Research and Development Program
Zitieren
APA
Mei, S., Ma, X., Zhou, L., Wuyun, Q., Cai, Z., Yan, J., & Ding, H. (2025). CircSMAD3 represses VSMC phenotype switching and neointima formation via promoting hnRNPA1 ubiquitination degradation. Cell Proliferation. https://doi.org/10.1111/cpr.13742
Vancouver
Mei S, Ma X, Zhou L, Wuyun Q, Cai Z, Yan J, et al. CircSMAD3 represses VSMC phenotype switching and neointima formation via promoting hnRNPA1 ubiquitination degradation. Cell Proliferation. 2025. doi:10.1111/cpr.13742
BibTeX
@article{Mei2025,
author = {Mei, Shuai and Ma, Xiaozhu and Zhou, Li and Wuyun, Qidamugai and Cai, Ziyang and Yan, Jiangtao and Ding, Hu},
title = {CircSMAD3 represses VSMC phenotype switching and neointima formation via promoting hnRNPA1 ubiquitination degradation},
journal = {Cell Proliferation},
year = {2025},
doi = {10.1111/cpr.13742}
}
EUVIMED